Cite
HARVARD Citation
Blommestein, H. et al. (n.d.). Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands. Leukemia research. pp. 37-45. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Blommestein, H. et al. (n.d.). Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands. Leukemia research. pp. 37-45. [Online].